3 completed, 1 active not recruiting, 1 terminated. 3 Phase 2, 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Active not recruiting 1, Completed 1, Terminated 1 |
| Phase 3 | 2 | Completed 2 |
| Phase 1 | 1 | Terminated 1 |
Follow Antipyretics: new trials by email Literature Review of Antipyretics trials Research Report on Antipyretics
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of YW17 (Laronidase-CinnaGen) Compared to Aldurazyme® in MPS I Patients Laronidase, Antihistamine, Antipyretic - Mucopolysaccharidosis Type 1 | Phase 3 | Completed | Cinnagen | 12 | 2022-09-10 | 2024-08-06 |
| 131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma Irinotecan, Temozolomide, Bevacizumab - Recurrent Medulloblastoma, Recurrent Ependymoma | Phase 2 | Active not recruiting | Pediatric Brain Tumor Consortium | 62 | 2022-04-04 | 2026-07-28 |
| Safety, Tolerability, and Pharmacokinetics of UX053 in Patients With Glycogen Storage Disease Type III (GSD III) UX053, Placebo, Antipyretic - Glycogen Storage Disease Type III | Phase 1 / Phase 2 | Terminated | Ultragenyx Pharmaceutical Inc | 9 | 2021-10-18 | 2024-04-16 |
| Safety and Immunogenicity in Dose-Ranging and Formulation-Finding Meningococcal B (MenB) Vaccine Study in 2-month-old Infants Meningococcal B vaccine, Control, Meningococcal B vaccine with antipyretic - Meningococcal Meningitis, Meningococcal Infections | Phase 2 | Completed | Novartis Vaccines | 1507 | 2009-07-01 | 2015-04-07 |
| A Study of Rituximab Alternative Dosing Rate in Patients With Previously Untreated Diffuse Large B-cell or Follicular Non-Hodgkin's Lymphoma (RATE) Rituximab, CHOP (cyclophosphamide, hydroxydaunorubicin [doxorubicin], Oncovin [vincristine], prednisone), CVP (cyclophosphamide, vincristine, prednisone) - Non-Hodgkin's Lymphoma | Phase 3 | Completed | Genentech, Inc. | 451 | 2008-07-01 | 2017-05-15 |
Ependymoma (1) · Glycogen Storage Disease Type III (1) · Lymphoma, Non-Hodgkin (1) · Medulloblastoma (1) · Meningitis (1) · Meningitis, Meningococcal (1) · Meningococcal Infections (1) · Mucopolysaccharidosis I (1)
Cinnagen (1) · Genentech, Inc. (1) · Novartis Vaccines (1) · Pediatric Brain Tumor Consortium (1) · Ultragenyx Pharmaceutical Inc (1)
Italy (2) · United States (2) · Argentina (1) · Chile (1) · Czechia (1) · Hungary (1) · Iran (1) · Spain (1)
Ali Rabani, Professor (1) · Deborah Hurst, M.D. (1) · Matthias Karajannis, MD, MS (1)
PMID 25424810, PMID 35257644, PMID 40830667
2009 (1), UM1CA081457 (1)